{"id":1532,"date":"2025-01-21T15:24:24","date_gmt":"2025-01-21T13:24:24","guid":{"rendered":"https:\/\/stephenindustries.com\/?p=1532"},"modified":"2025-01-21T15:26:37","modified_gmt":"2025-01-21T13:26:37","slug":"stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista","status":"publish","type":"post","link":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/","title":{"rendered":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4"},"content":{"rendered":"\n<p>Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen, jonka tavoitteena on tukea Endometriosis hoitoon suunnatun hormoonivapaan l\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4.&#13;\n&#13;\nEndometrioosi on kivulias, krooninen tulehduksellinen sairaus, joka heikent\u00e4\u00e4 merkitt\u00e4v\u00e4sti yli 10 %:n lis\u00e4\u00e4ntymisik\u00e4\u00e4n kuuluvien naisten terveytt\u00e4 ja el\u00e4m\u00e4nlaatua.<\/p>\n\n<p>Gesynta Pharma kehitt\u00e4\u00e4 vipoglanstatia, uutta hormonivapaata l\u00e4\u00e4keainetta endometrioosin hoitoon. Vipoglanstat est\u00e4\u00e4 mPGES-1-entsyymin toimintaa, joka on yliaktiivinen endometrioosipes\u00e4kkeiss\u00e4 ja aiheuttaa sek\u00e4 kipua ett\u00e4 pes\u00e4kkeiden kasvua.<\/p>\n\n<p>Lis\u00e4tietoa aiheesta: <a href=\"https:\/\/www.gesynta.se\/\">www.gesynta.se<\/a><\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen, jonka tavoitteena on tukea Endometriosis hoitoon suunnatun hormoonivapaan l\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4.&#13; &#13; Endometrioosi on kivulias, krooninen tulehduksellinen sairaus, joka heikent\u00e4\u00e4 merkitt\u00e4v\u00e4sti yli 10 %:n lis\u00e4\u00e4ntymisik\u00e4\u00e4n kuuluvien naisten terveytt\u00e4 ja el\u00e4m\u00e4nlaatua. Gesynta Pharma kehitt\u00e4\u00e4 vipoglanstatia, uutta hormonivapaata l\u00e4\u00e4keainetta endometrioosin hoitoon. Vipoglanstat est\u00e4\u00e4 mPGES-1-entsyymin toimintaa, joka on yliaktiivinen endometrioosipes\u00e4kkeiss\u00e4 ja [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-1532","post","type-post","status-publish","format-standard","hentry","category-uncategorized-fi"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4 - Stephen Industries<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\" \/>\n<meta property=\"og:locale\" content=\"fi_FI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4 - Stephen Industries\" \/>\n<meta property=\"og:description\" content=\"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen, jonka tavoitteena on tukea Endometriosis hoitoon suunnatun hormoonivapaan l\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4.&#013; &#013; Endometrioosi on kivulias, krooninen tulehduksellinen sairaus, joka heikent\u00e4\u00e4 merkitt\u00e4v\u00e4sti yli 10 %:n lis\u00e4\u00e4ntymisik\u00e4\u00e4n kuuluvien naisten terveytt\u00e4 ja el\u00e4m\u00e4nlaatua. Gesynta Pharma kehitt\u00e4\u00e4 vipoglanstatia, uutta hormonivapaata l\u00e4\u00e4keainetta endometrioosin hoitoon. Vipoglanstat est\u00e4\u00e4 mPGES-1-entsyymin toimintaa, joka on yliaktiivinen endometrioosipes\u00e4kkeiss\u00e4 ja [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\" \/>\n<meta property=\"og:site_name\" content=\"Stephen Industries\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-21T13:24:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-21T13:26:37+00:00\" \/>\n<meta name=\"author\" content=\"Lilli Wikstr\u00f6m\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Kirjoittanut\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lilli Wikstr\u00f6m\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\"},\"author\":{\"name\":\"Lilli Wikstr\u00f6m\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095\"},\"headline\":\"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4\",\"datePublished\":\"2025-01-21T13:24:24+00:00\",\"dateModified\":\"2025-01-21T13:26:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\"},\"wordCount\":92,\"publisher\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/#organization\"},\"articleSection\":[\"Uncategorized @fi\"],\"inLanguage\":\"fi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\",\"url\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\",\"name\":\"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4 - Stephen Industries\",\"isPartOf\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/#website\"},\"datePublished\":\"2025-01-21T13:24:24+00:00\",\"dateModified\":\"2025-01-21T13:26:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/#breadcrumb\"},\"inLanguage\":\"fi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/stephenindustries.com\/fi\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/#website\",\"url\":\"https:\/\/stephenindustries.com\/fi\/\",\"name\":\"Stephen Industries\",\"description\":\"Creating futures since 1992\",\"publisher\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stephenindustries.com\/fi\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fi\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/#organization\",\"name\":\"Stephen Industries\",\"url\":\"https:\/\/stephenindustries.com\/fi\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fi\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg\",\"contentUrl\":\"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg\",\"width\":265,\"height\":75,\"caption\":\"Stephen Industries\"},\"image\":{\"@id\":\"https:\/\/stephenindustries.com\/fi\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095\",\"name\":\"Lilli Wikstr\u00f6m\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fi\",\"@id\":\"https:\/\/stephenindustries.com\/fi\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g\",\"caption\":\"Lilli Wikstr\u00f6m\"},\"sameAs\":[\"http:\/\/stephenindustries.com\"],\"url\":\"https:\/\/stephenindustries.com\/fi\/author\/lilli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4 - Stephen Industries","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/","og_locale":"fi_FI","og_type":"article","og_title":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4 - Stephen Industries","og_description":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen, jonka tavoitteena on tukea Endometriosis hoitoon suunnatun hormoonivapaan l\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4.&#13; &#13; Endometrioosi on kivulias, krooninen tulehduksellinen sairaus, joka heikent\u00e4\u00e4 merkitt\u00e4v\u00e4sti yli 10 %:n lis\u00e4\u00e4ntymisik\u00e4\u00e4n kuuluvien naisten terveytt\u00e4 ja el\u00e4m\u00e4nlaatua. Gesynta Pharma kehitt\u00e4\u00e4 vipoglanstatia, uutta hormonivapaata l\u00e4\u00e4keainetta endometrioosin hoitoon. Vipoglanstat est\u00e4\u00e4 mPGES-1-entsyymin toimintaa, joka on yliaktiivinen endometrioosipes\u00e4kkeiss\u00e4 ja [&hellip;]","og_url":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/","og_site_name":"Stephen Industries","article_published_time":"2025-01-21T13:24:24+00:00","article_modified_time":"2025-01-21T13:26:37+00:00","author":"Lilli Wikstr\u00f6m","twitter_card":"summary_large_image","twitter_misc":{"Kirjoittanut":"Lilli Wikstr\u00f6m"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/#article","isPartOf":{"@id":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/"},"author":{"name":"Lilli Wikstr\u00f6m","@id":"https:\/\/stephenindustries.com\/fi\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095"},"headline":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4","datePublished":"2025-01-21T13:24:24+00:00","dateModified":"2025-01-21T13:26:37+00:00","mainEntityOfPage":{"@id":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/"},"wordCount":92,"publisher":{"@id":"https:\/\/stephenindustries.com\/fi\/#organization"},"articleSection":["Uncategorized @fi"],"inLanguage":"fi"},{"@type":"WebPage","@id":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/","url":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/","name":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4 - Stephen Industries","isPartOf":{"@id":"https:\/\/stephenindustries.com\/fi\/#website"},"datePublished":"2025-01-21T13:24:24+00:00","dateModified":"2025-01-21T13:26:37+00:00","breadcrumb":{"@id":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/#breadcrumb"},"inLanguage":"fi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stephenindustries.com\/fi\/stephen-industries-osallistui-gesynta-pharma-abn-tuoreimpaan-rahoituskierrokseen-tukeakseen-endometrioosilaakkeen-kehittamista\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stephenindustries.com\/fi\/"},{"@type":"ListItem","position":2,"name":"Stephen Industries osallistui Gesynta Pharma AB:n tuoreimpaan rahoituskierrokseen tukeakseen endometrioosil\u00e4\u00e4kkeen kehitt\u00e4mist\u00e4"}]},{"@type":"WebSite","@id":"https:\/\/stephenindustries.com\/fi\/#website","url":"https:\/\/stephenindustries.com\/fi\/","name":"Stephen Industries","description":"Creating futures since 1992","publisher":{"@id":"https:\/\/stephenindustries.com\/fi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stephenindustries.com\/fi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fi"},{"@type":"Organization","@id":"https:\/\/stephenindustries.com\/fi\/#organization","name":"Stephen Industries","url":"https:\/\/stephenindustries.com\/fi\/","logo":{"@type":"ImageObject","inLanguage":"fi","@id":"https:\/\/stephenindustries.com\/fi\/#\/schema\/logo\/image\/","url":"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg","contentUrl":"https:\/\/stephenindustries.com\/wp-content\/uploads\/2024\/01\/stephen-industries-logo.svg","width":265,"height":75,"caption":"Stephen Industries"},"image":{"@id":"https:\/\/stephenindustries.com\/fi\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stephenindustries.com\/fi\/#\/schema\/person\/2ef2aeaec24e66ab1c85a6be2f240095","name":"Lilli Wikstr\u00f6m","image":{"@type":"ImageObject","inLanguage":"fi","@id":"https:\/\/stephenindustries.com\/fi\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1a73893abd00f142995c585834d16f19d75845858cb4a570577f8d09e4e768c?s=96&d=mm&r=g","caption":"Lilli Wikstr\u00f6m"},"sameAs":["http:\/\/stephenindustries.com"],"url":"https:\/\/stephenindustries.com\/fi\/author\/lilli\/"}]}},"_links":{"self":[{"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/posts\/1532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/comments?post=1532"}],"version-history":[{"count":3,"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/posts\/1532\/revisions"}],"predecessor-version":[{"id":1536,"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/posts\/1532\/revisions\/1536"}],"wp:attachment":[{"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/media?parent=1532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/categories?post=1532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stephenindustries.com\/fi\/wp-json\/wp\/v2\/tags?post=1532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}